{
    "2014-05-17": [
        "RT @MarkSchoenebaum: CELG/ACT markman: ACT implies the x-ray diffraction patent for their polymorph does not align with CEL",
        "RT @MarkSchoenebaum: My lawyer says CELGs arguments are a bit stronger technically, but doesnt expect the judge to give either a major advantage in",
        "RT @MarkSchoenebaum: CELG/ACT markman ongoing: The parties agreed on the construction of the terms unit dosage, the chemical name, and",
        "BIG Wow. Great Stock Research on MO CELG DO Worth a look"
    ]
}